Antidepressant treatment history as a predictor of response to scopolamine: Clinical implications

Journal of Affective Disorders

Volumn 162, Issue , 2014, Pages 39-42

  Ellis, Jessica S ^a   Zarate Jr , Carlos A ^a   Luckenbaugh, David A ^a   Furey, Maura L ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Antidepressant; Depression; Scopolamine; Treatment history; Treatment resistant

Indexed keywords

ANTIDEPRESSANT AGENT; SCOPOLAMINE; SCOPOLAMINE BROMIDE;

ADULT; ANTIDEPRESSANT ACTIVITY; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG TREATMENT FAILURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OUTCOME ASSESSMENT; PATIENT HISTORY OF THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT RESISTANT DEPRESSION; TREATMENT RESPONSE; ADOLESCENT; DEPRESSIVE DISORDER, MAJOR; METHODOLOGY; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; CROSS-OVER STUDIES; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RESEARCH DESIGN; SCOPOLAMINE HYDROBROMIDE; YOUNG ADULT;

EID: 84898654709     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2014.03.010     Document Type: Article

References (16)

1. American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental Disorders, IV, Text Revision. American Psychiatric Association: Washington DC.
2. W. Drevets, and M. Furey Replication of scopolamine's antidepressant efficacy: a randomized, placebo-controlled clinical trial Biol. Psychiatry. 67 2010 432 438
3. M. Fava, and K. Davidson Definition and epidemiology of treatment-resistant depression Psychiatr. Clin. North Am. 19 1996 179 200
4. M. Furey, and W. Drevets Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial Arch. Gen. Psychiatry. 63 2006 1121 1129 (Pubitemid 44498391)
5. M. Furey, A. Khanna, E. Hoffman, and W. Drevets Scopolamine produces larger antidepressant and antianxiety effects in women than in men Neuropsychopharmacology 35 2010 2479 2488
6. T. Insel, and P. Wang The STAR D trial: revealing the need for better treatments Psychiatr. Serv. 60 2009 1466 1467
7. D. Janowsky, and D. Overstreet Cholinergic dysfunction in depression Pharmacol. Toxicol. 66 1990 100 111 (Pubitemid 20110989)
8. R. Kessler, W.T. Chiu, O. Demler, and E.E. Walters Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R) Arch. Gen. Psychiatry. 62 2005 617 627 (Pubitemid 40973437)
9. A. Khan, S.R. Khan, E.B. Shankles, and N.L. Polissar Relative sensitivity of the Montgomery-Asberg Depression rating scale, the Hamilton Depression rating scale and the Clinical Global Impressions rating scale in antidepressant clinical trials Int. Clin. Psychopharmacol. 17 2002 281 285 (Pubitemid 35283715)
10. M. Maes, E. Bosmans, R. De Jongh, G. Kenis, E. Vandoolaeghe, and H. Neels Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression Cytokine 9 1997 853 858 (Pubitemid 27494150)
11. P.J. McGrath, J.W. Stewart, M. Fava, M.H. Trivedi, S.R. Wisniewski, A.A. Nierenberg, M.E. Thase, L. Davis, M.M. Biggs, K. Shores-Wilson, J.F. Luther, G. Niederehe, D. Warden, and A.J. Rush Tranylcypromine versus Venlafaxine plus Mirtazapine following three failed antidepressant medication trials for depression: a STAR D report Am. J. Psychiatry. 163 2006 1531 1541 (Pubitemid 44465752)
12. A. Nierenberg, and L. DeCecco Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression J. Clin. Psychiatry. 62 2001 5 9
13. A.A. Nierenberg, M. Fava, M.H. Trivedi, S.R. Wisniewski, M.E. Thase, P.J. McGrath, J.E. Alpert, D. Warden, J.F. Luther, G. Niederehe, B. Lebowitz, K. Shores-Wilson, and A.J. Rush A comparison of lithium and T3 augmentation following two failed medication treatments for depression: a STAR D report Am. J. Psychiatry. 163 2006 1519 1530 (Pubitemid 44465751)
14. A.J. Rush, M.H. Trivedi, S.R. Wisniewski, A.A. Nierenberg, J.W. Stewart, D. Warden, G. Niederehe, M.E. Thase, P.W. Lavori, B.D. Lebowitz, P.J. McGrath, J.F. Rosenbaum, H.A. Sackheim, D.J. Kupfer, J. Luther, and M. Fava Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR D report Am. J. Psychiatry. 163 2006 1905 1917 (Pubitemid 44807782)
15. H. Sackeim The definition and meaning of treatment-resistant depression J. Clin. Psychiatry. 62 2001 10 17
16. US Census Bureau. 2013. US Census Bureau. Available at: http://www.census.gov/popest/national/asrh/. [Accessed 05 October 2013].